Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Garufi

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Lupus|October 19, 2019
Complementemia in pregnancies with antiphospholipid syndromeS Tabacco, A Giannini, C Garufi, et al.
Cancer|March 10, 2001
Irinotecan and chronomodulated infusion of 5-fluorouracil and folinic acid in the treatment of patients with advanced colorectal carcinoma: a phase I studyC Garufi, L Dogliotti, R M D'Attino, et al.
Journal of the National Cancer Institute|November 2, 1994
Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trialF A Lévi, R Zidani, J M Vannetzel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancerE Van Cutsem, C Pozzo, H Starkhammar, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancerC Garufi, F Lévi, A M Aschelter, et al.
Lupus|June 30, 2018
Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohortF R Spinelli, E Moscarelli, F Ceccarelli, et al.
Anti-Cancer Drugs|September 23, 2000
Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patientsC Garufi, S Brienza, P Pugliese, et al.
European Journal of Cancer (Oxford, England : 1990)|April 22, 2008
P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: distribution and prognostic relevanceA Torsello, C Garufi, M Cosimelli, et al.
Tumori|November 6, 2001
Preoperative chemoradiation and total mesorectal excision surgery for low T3 rectal cancerM Cosimelli, R Mancini, M Tedesco, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 10, 2004
Single-agent vinorelbine in pretreated breast cancer patients: comparison of two different schedulesE Terzoli, C Nisticò, A Fabi, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Lupus|October 19, 2019
Complementemia in pregnancies with antiphospholipid syndromeS Tabacco, A Giannini, C Garufi, et al.
Cancer|March 10, 2001
Irinotecan and chronomodulated infusion of 5-fluorouracil and folinic acid in the treatment of patients with advanced colorectal carcinoma: a phase I studyC Garufi, L Dogliotti, R M D'Attino, et al.
Journal of the National Cancer Institute|November 2, 1994
Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trialF A Lévi, R Zidani, J M Vannetzel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancerE Van Cutsem, C Pozzo, H Starkhammar, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancerC Garufi, F Lévi, A M Aschelter, et al.
Lupus|June 30, 2018
Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohortF R Spinelli, E Moscarelli, F Ceccarelli, et al.
Anti-Cancer Drugs|September 23, 2000
Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patientsC Garufi, S Brienza, P Pugliese, et al.
European Journal of Cancer (Oxford, England : 1990)|April 22, 2008
P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: distribution and prognostic relevanceA Torsello, C Garufi, M Cosimelli, et al.
Tumori|November 6, 2001
Preoperative chemoradiation and total mesorectal excision surgery for low T3 rectal cancerM Cosimelli, R Mancini, M Tedesco, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 10, 2004
Single-agent vinorelbine in pretreated breast cancer patients: comparison of two different schedulesE Terzoli, C Nisticò, A Fabi, et al.
Pageof 6